Chinese healthtech platform Liangyihui and precision medicine firm Chigene have raised over 100 million yuan ($15.5 million) each to fund product research and development.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
